WASHINGTON: The
United States government will pay Johnson & Johnson over $1 billion for 100 million doses of its
investigational coronavirus vaccine, the
drugmaker said on Wednesday.
It said it will deliver the vaccine to Biomedical Advanced Research and Development Authority (BARDA) on a not-for-profit basis to be used after approval or emergency use authorization by the U.S. Food and Drug Administration (FDA).
J&J's investigational vaccine is currently being tested on healthy volunteers in the United States and Belgium in an early stage study.